11/02/2016 - 12:20pm

Ajanta has launched its generic of Azor, a high blood pressure treatment. 

11/01/2016 - 12:45pm

The drug  had U.S. sales of $911 million for the 12 months ended September 2016, according to QuintilesIMS data.

10/31/2016 - 1:00pm

Camber Pharmaceuticals on Monday announced the launch of its Crestor (rosuvastatin) generic. The drug is indicated to treat high triglycerides and cholesterol.

10/31/2016 - 12:09pm

Under the agreement, AstraZeneca will continue to manufacture and supply the drug and its authorized generic to Aralex Ireland for at least 10 years, and it will continue to distribute the product until it is transferred, which could be up to nine months after closing. 

10/28/2016 - 2:31pm
Bloomberg BNA is reporting that the Food and Drug Administration’s director of the Center for Drug Evaluation and Research’s Office of New Drugs told an audience at the DIA Biosimilars Conference that manufacturers looking to submit an application for biosimilar approval should know what the FDA is looking for when evaluating a biosmilar for approval. Jenkins said that rather than the focus on safety and efficacy it places on standalone biologics, with biosimilars, it focvuses on how closely it resembles the reference product, something he called “a work in progress” for some drug makers. (Bloomberg BNA)
 
10/28/2016 - 2:19pm

The drug is indicated to temporarily relieve cold, flu, allergy or other breathing illness symptoms. 

10/28/2016 - 1:00pm

The launch marks the first for a generic of Benicar and Benicar HCT, which have a combined market size of $1.8 billion, according to IMS Health data for the 12 months ended Aug. 31. 

10/27/2016 - 11:36am

NEW YORK - The giant AT&T-Time Warner merger may bring individualized ads - already commonplace on such streaming services as Hulu or YouTube - to network television, The New York Times reported Wednesday. "If you believe in a future where the very, very fine targeting of households or individuals with specific messaging makes economic sense to do at scale, what this merger does is enable that by making more audience available to target in that way,” Rob Norman, chief digital officer of WPP's GroupM, told The Times. “The question will be: What is the premium for addressability for that level of targeting that the advertiser is willing to pay?” (The New York Times)

10/26/2016 - 1:17pm

Aurobindo’s generic will be available in 1-, 2- and 3-mg dosage strengths.